Search Results

You are looking at 1 - 10 of 10 items for :

  • "trimetazidine" x
  • Medical and Health Sciences x
  • All content x
Clear All

WW. Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials. Coron Artery Dis. 2003; 14: 171–179. 3

Open access

, et al. Heart rate and use of beta-blockers in stable outpatients with coronary artery disease. PloS ONE 2012; 7: e36284. 11 Dézsi CA. Trimetazidine in practice: review of

Restricted access

Hungary: Cross-sectional study on nationally representative sample of people aged 20–69 years. Croat. Med. J., 2010, 51 (2), 151–156. 3 Dézsi, C. A.: Trimetazidine

Open access

trimetazidine in cochleovestibular disorders of ischemic origin. A crossover control versus placebo trial Annales d'Oto-Larygologe et de Chirurge Cervico-Faciale 1 107Suppl 81 – 87 . [42]. R. Belardinelli M. Solenghi L. Volpe 2007

Restricted access

22 797 801 Coyas, A.: The efficacy of trimetazidine in cochleovostibular disorders of ischemic origin. A crossover control versus

Restricted access

22 797 801 Coyas, A.: The efficacy of trimetazidine in cochleovestibular disorders of ischemic origin. A crossover control versus

Restricted access

.: Differential effects of trimetazidine on vascular smooth muscle cell and endothelial cell in response to carotid artery balloon injury in diabetic rats. Int. J. Cardiol., 2013, 167 (1), 126

Restricted access

MacInnes A, Fairman DA, Binding P, Rhodes Ja, Wyatt MJ, Phelan A, Haddock PS, Karran EH: The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ. Res. 93, e26

Restricted access

1936 Marzilli, M., Klein, W.: Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double blind, controlled trials. Coronary Artery Dis

Restricted access

MacInnes A, Fairman DA, Binding P, Rhodes J, Wyatt MJ, Phelan A, Haddock PS, Karran EH: The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ. Res. 93, e26–e

Restricted access